Larson Financial Group’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18.1K | Buy |
119
+42
| +55% | +$6.37K | ﹤0.01% | 1526 |
|
|
2025
Q1 | $11.6K | Buy |
77
+70
| +1,000% | +$10.5K | ﹤0.01% | 1568 |
|
|
2024
Q4 | $1.29K | Sell |
7
-82
| -92% | -$15.1K | ﹤0.01% | 1960 |
|
|
2024
Q3 | $17.5K | Buy |
89
+65
| +271% | +$12.8K | ﹤0.01% | 1259 |
|
|
2024
Q2 | $4.96K | Buy |
24
+16
| +200% | +$3.31K | ﹤0.01% | 1446 |
|
|
2024
Q1 | $2.17K | Sell |
8
-5
| -38% | -$1.36K | ﹤0.01% | 1346 |
|
|
2023
Q4 | $3.07K | Sell |
13
-1
| -7% | -$236 | ﹤0.01% | 1287 |
|
|
2023
Q3 | $2.74K | Buy |
14
+3
| +27% | +$588 | ﹤0.01% | 1292 |
|
|
2023
Q2 | $2.31K | Hold |
11
| – | – | ﹤0.01% | 1246 |
|
|
2023
Q1 | $2.22K | Hold |
11
| – | – | ﹤0.01% | 1227 |
|
|
2022
Q4 | $2.4K | Hold |
11
| – | – | ﹤0.01% | 1162 |
|
|
2022
Q3 | $2K | Hold |
11
| – | – | ﹤0.01% | 1102 |
|
|
2022
Q2 | $2K | Buy |
11
+5
| +83% | +$909 | ﹤0.01% | 1018 |
|
|
2022
Q1 | $2K | Hold |
6
| – | – | ﹤0.01% | 904 |
|
|
2021
Q4 | $2K | Hold |
6
| – | – | ﹤0.01% | 937 |
|
|
2021
Q3 | $2K | Hold |
6
| – | – | ﹤0.01% | 772 |
|
|
2021
Q2 | $2K | Sell |
6
-3
| -33% | -$1K | ﹤0.01% | 718 |
|
|
2021
Q1 | $3K | Hold |
9
| – | – | ﹤0.01% | 664 |
|
|
2020
Q4 | $2K | Hold |
9
| – | – | ﹤0.01% | 625 |
|
|
2020
Q3 | $2K | Buy |
9
+6
| +200% | +$1.33K | ﹤0.01% | 586 |
|
|
2020
Q2 | $1K | Hold |
3
| – | – | ﹤0.01% | 594 |
|
|
2020
Q1 | $0 | Hold |
3
| – | – | ﹤0.01% | 552 |
|
|
2019
Q4 | $0 | Buy |
+3
| New | – | ﹤0.01% | 589 |
|